Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials

Antipsychotic-induced dyslipidemia could increase the risk of cardiovascular diseases. This is a meta-analysis of randomized double-blind placebo-controlled trials to examine the efficacy and safety of adjunctive metformin for dyslipidemia induced by antipsychotics in schizophrenia. The standardized...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Psychiatry
Glavni autori: Jiang, Wen-Long, Cai, Dong-Bin, Yin, Fei, Zhang, Ling, Zhao, Xi-Wu, He, Jie, Ng, Chee H., Ungvari, Gabor S., Sim, Kang, Hu, Mei-Ling, Zheng, Wei, Xiang, Yu-Tao
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2020
Teme:
Review Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7181777/
https://ncbi.nlm.nih.gov/pubmed/32327628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-020-0785-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items